A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058)
Clinical trial NCT06811246 · COMPLETED
Trial details
- NCT number
- NCT06811246
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-07
- Primary completion
- 2024-07-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.